Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
240 participants
OBSERVATIONAL
2020-01-16
2022-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Investigators prospect to recruit subjects including patients and controls amount to 240. All subjects will be collected for blood and stool samples,assessed by clinical scales. Finally, analyzing the correlation among the metabolon in blood, microbiota in stool and clinical scales to obtain the possible interaction between diseases and gut microbiota.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Gut Microbiota in Major Depressive Disorders With and Without Rapid Eye Movement Behavior Disorder
NCT05008120
Microbiome and the Gut-Brain Axis
NCT02693327
Intestinal Flora and Major Depressive Disorders
NCT04347577
The Clinical Research on the Relationship Between Depression and Gut Microbiota in TBI Patients
NCT02874027
A Study of the Efficacy of Fecal Microbiota Transplantation(FMT) in the Treatment of Depression
NCT05850572
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods:
1. Investigators aim at recruiting human subjects in total 240, which including mania episode of bipolar disorder (40), depressive episode of bipolar disorder (40), mixed episode of bipolar disorder (40), first episode of major depressive disorder (40), recurrent episode of major depressive disorder (40), and healthy control (40). All patients, diagnosed according to the research criteria of the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), come from The First Affiliated Hospital of Xi'an Jiaotong University and controls are healthy volunteers.
2. Collecting blood and stool samples, evaluating clinical scales including Montgomery-Asberg Depression Scale (MADRS), Young Mania Rating Scale (YMRS), Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Measurement And Treatment Research To Improve Cognition In Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB), Clinical Global Impression (CGI) are all finished in first day after threshold.
3. Measure the metabolon in blood such as S-CFA, and gut microbiota.
4. Using Statistical Program for Social Sciences (SPSS) to compare general and clinical data among groups and analyze the correlation between the microbiota and symptoms.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Bipolar disorder,mania
The group includes subjects who are diagnosed to mania episode of bipolar disorder.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
Bipolar disorder,depressive
The group includes subjects who are diagnosed to depression episode of bipolar disorder.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
Bipolar disorder,mixed
The group includes subjects who are diagnosed to mixed episode of bipolar disorder.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
First episode major depression
The group includes subjects who are diagnosed to first episode of major depression.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
major depression,recurrent
The group includes subjects who are diagnosed to recurrent episode of major depression.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
Healthy control
The group includes subjects who are Healthy control.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Faecal genome
Sequencing faecal genome is not the intervention measure.It is the Observational method to detect the component of faecal microbiota.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Take antibiotics continuously less than 3 days in recent 3 months.
* 17.5≦BMI≦30
* Age≦65
Exclusion Criteria
* pregnant or lactational women
* who is diagnosed with mental retardation.
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
First Affiliated Hospital Xi'an Jiaotong University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Xiancang Ma, professor
Role: STUDY_DIRECTOR
First Affiliated Hospital Xi'an Jiaotong University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Xiancang Ma
Xi'an, Shaanxi, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TGMOBAD2017
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.